Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-l-carnitine administration

Benedetto Falsini, Vittorio Porciatti, Roberto Bolzani, Antonello Marchionni

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Acetyl-l-carnitine (LAC) is a neuroactive compound that is thought to be involved in cholinergic transmission. The effects of acute intravenous LAC administration (30 mg/kg) on pattern-evoked electroretinograms (P-ERGS) were evaluated in nine healthy volunteers ranging in age between 21 and 27 years. Nine age-matched, normal subjects treated with a placebo served as controls. Steady-state (8 Hz) P-ERGS recorded in response to counterphased sinusoidal gratings of variable spatial frequency (0.6-4.8 cycles/degree) were obtained before and at 20, 50 and 80 min after LAC or placebo administration. The amplitude and phase of the Fourier-analysed P-ERG second harmonic were measured. As compared with placebo-treated controls, LAC-treated subjects showed a selective P-ERG amplitude increase (Mann-Whitney rank test: P < 0.05), which was found 80 min posttreatment at a spatial frequency of 4.8 cycles/degree. For the same stimulus a significant (P < 0.05) P-ERG phase shortening (at 50 min after drug administration) was also found. The spatial frequencies of other stimuli did not show a significant difference between the LAC- and placebo-treated groups. These results indicate that acute LAC administration induces a spatial-frequency-dependent enhancement of the human P-ERG. This is compatible with a cholinergic excitatory effect and suggests a therapeutic role for this compound in retinal dysfunctions with selective vulnerability to medium-high spatial frequencies.

Original languageEnglish
Pages (from-to)262-266
Number of pages5
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume229
Issue number3
DOIs
StatePublished - May 1 1991
Externally publishedYes

Fingerprint

Acetylcarnitine
Placebos
Cholinergic Agents
Intravenous Administration
Healthy Volunteers
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-l-carnitine administration. / Falsini, Benedetto; Porciatti, Vittorio; Bolzani, Roberto; Marchionni, Antonello.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 229, No. 3, 01.05.1991, p. 262-266.

Research output: Contribution to journalArticle

@article{d095d98f625647e08d4e468d6ba3b411,
title = "Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-l-carnitine administration",
abstract = "Acetyl-l-carnitine (LAC) is a neuroactive compound that is thought to be involved in cholinergic transmission. The effects of acute intravenous LAC administration (30 mg/kg) on pattern-evoked electroretinograms (P-ERGS) were evaluated in nine healthy volunteers ranging in age between 21 and 27 years. Nine age-matched, normal subjects treated with a placebo served as controls. Steady-state (8 Hz) P-ERGS recorded in response to counterphased sinusoidal gratings of variable spatial frequency (0.6-4.8 cycles/degree) were obtained before and at 20, 50 and 80 min after LAC or placebo administration. The amplitude and phase of the Fourier-analysed P-ERG second harmonic were measured. As compared with placebo-treated controls, LAC-treated subjects showed a selective P-ERG amplitude increase (Mann-Whitney rank test: P < 0.05), which was found 80 min posttreatment at a spatial frequency of 4.8 cycles/degree. For the same stimulus a significant (P < 0.05) P-ERG phase shortening (at 50 min after drug administration) was also found. The spatial frequencies of other stimuli did not show a significant difference between the LAC- and placebo-treated groups. These results indicate that acute LAC administration induces a spatial-frequency-dependent enhancement of the human P-ERG. This is compatible with a cholinergic excitatory effect and suggests a therapeutic role for this compound in retinal dysfunctions with selective vulnerability to medium-high spatial frequencies.",
author = "Benedetto Falsini and Vittorio Porciatti and Roberto Bolzani and Antonello Marchionni",
year = "1991",
month = "5",
day = "1",
doi = "10.1007/BF00167881",
language = "English",
volume = "229",
pages = "262--266",
journal = "Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie",
issn = "0065-6100",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-l-carnitine administration

AU - Falsini, Benedetto

AU - Porciatti, Vittorio

AU - Bolzani, Roberto

AU - Marchionni, Antonello

PY - 1991/5/1

Y1 - 1991/5/1

N2 - Acetyl-l-carnitine (LAC) is a neuroactive compound that is thought to be involved in cholinergic transmission. The effects of acute intravenous LAC administration (30 mg/kg) on pattern-evoked electroretinograms (P-ERGS) were evaluated in nine healthy volunteers ranging in age between 21 and 27 years. Nine age-matched, normal subjects treated with a placebo served as controls. Steady-state (8 Hz) P-ERGS recorded in response to counterphased sinusoidal gratings of variable spatial frequency (0.6-4.8 cycles/degree) were obtained before and at 20, 50 and 80 min after LAC or placebo administration. The amplitude and phase of the Fourier-analysed P-ERG second harmonic were measured. As compared with placebo-treated controls, LAC-treated subjects showed a selective P-ERG amplitude increase (Mann-Whitney rank test: P < 0.05), which was found 80 min posttreatment at a spatial frequency of 4.8 cycles/degree. For the same stimulus a significant (P < 0.05) P-ERG phase shortening (at 50 min after drug administration) was also found. The spatial frequencies of other stimuli did not show a significant difference between the LAC- and placebo-treated groups. These results indicate that acute LAC administration induces a spatial-frequency-dependent enhancement of the human P-ERG. This is compatible with a cholinergic excitatory effect and suggests a therapeutic role for this compound in retinal dysfunctions with selective vulnerability to medium-high spatial frequencies.

AB - Acetyl-l-carnitine (LAC) is a neuroactive compound that is thought to be involved in cholinergic transmission. The effects of acute intravenous LAC administration (30 mg/kg) on pattern-evoked electroretinograms (P-ERGS) were evaluated in nine healthy volunteers ranging in age between 21 and 27 years. Nine age-matched, normal subjects treated with a placebo served as controls. Steady-state (8 Hz) P-ERGS recorded in response to counterphased sinusoidal gratings of variable spatial frequency (0.6-4.8 cycles/degree) were obtained before and at 20, 50 and 80 min after LAC or placebo administration. The amplitude and phase of the Fourier-analysed P-ERG second harmonic were measured. As compared with placebo-treated controls, LAC-treated subjects showed a selective P-ERG amplitude increase (Mann-Whitney rank test: P < 0.05), which was found 80 min posttreatment at a spatial frequency of 4.8 cycles/degree. For the same stimulus a significant (P < 0.05) P-ERG phase shortening (at 50 min after drug administration) was also found. The spatial frequencies of other stimuli did not show a significant difference between the LAC- and placebo-treated groups. These results indicate that acute LAC administration induces a spatial-frequency-dependent enhancement of the human P-ERG. This is compatible with a cholinergic excitatory effect and suggests a therapeutic role for this compound in retinal dysfunctions with selective vulnerability to medium-high spatial frequencies.

UR - http://www.scopus.com/inward/record.url?scp=0025736176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025736176&partnerID=8YFLogxK

U2 - 10.1007/BF00167881

DO - 10.1007/BF00167881

M3 - Article

C2 - 1869064

AN - SCOPUS:0025736176

VL - 229

SP - 262

EP - 266

JO - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

JF - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

SN - 0065-6100

IS - 3

ER -